Neuroinflammatory conditions

Anti-Contactin-1 Nodopathy Presenting With Dysphagia and Nephrotic Syndrome: Remarkable Neurological and Renal Recovery Following Early B-Cell-Targeted Therapy

Study Overview The research illustrated a unique case involving a patient diagnosed with anti-Contactin-1 nodopathy, a rare neurological disorder characterized

Anti-Contactin-1 Nodopathy Presenting With Dysphagia and Nephrotic Syndrome: Remarkable Neurological and Renal Recovery Following Early B-Cell-Targeted Therapy Read Post »

Natalizumab and Tyruko (natalizumab biosimilar) for treating highly active relapsing-remitting multiple sclerosis after at least one disease-modifying therapy: a systematic review and economic model

Natalizumab and Tyruko in Multiple Sclerosis Therapy Natalizumab is a monoclonal antibody that targets the alpha-4 integrin subunit, inhibiting the

Natalizumab and Tyruko (natalizumab biosimilar) for treating highly active relapsing-remitting multiple sclerosis after at least one disease-modifying therapy: a systematic review and economic model Read Post »

Scroll to Top